(Q34403658)

1 August 2017

The pharmacokinetics of intravenous ondansetron in patients with hepatic impairment (English)

1 reference

1 August 2017

1 reference

Blake JC

1

1 reference

1 August 2017

Palmer JL

series ordinal

2

1 reference

1 August 2017

Minton NA

series ordinal

3

1 reference

1 August 2017

Burroughs AK

series ordinal

4

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 April 1993

1 reference

British Journal of Clinical Pharmacology

1 August 2017

1 reference

1 August 2017

35

1 reference

1 August 2017

4

1 reference

1 August 2017

441-443

1 reference

Drug metabolism in liver disease

1 August 2017

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1381558

Pharmacological and anti-emetic properties of ondansetron.

6 July 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1381558

Determination of Ondansetron in Plasma and Its Pharmacokinetics in the Young and Elderly

6 July 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/8485026

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Age and gender effects on ondansetron pharmacokinetics: evaluation of healthy aged volunteers

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/8485026

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The metabolism of ondansetron

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/8485026

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1111/J.1365-2125.1993.TB04164.X

1 reference

1 August 2017

1 reference

1 August 2017

1 reference